Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Okun

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Biofizika|September 1, 1992
[Osmotic regulation of the sodium pump in rat brain synaptosomes]A A Mongin, S L Aksentsev, A A Rakovich, et al.
The British Journal of Dermatology|November 19, 2010
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapyK Papp, J Crowley, J-P Ortonne, et al.
Transactions of the American Clinical and Climatological Association|January 11, 2013
The impact of race on organ donation authorization discussed in the context of liver transplantationHenry C Bodenheimer, Jeffrey M Okun, Waheed Tajik, et al.
The British Journal of Dermatology|May 9, 2012
Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label studyC Leonardi, J M Sobell, J J Crowley, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitorsDmitri V Kravchenko, Vladimir V Kysil, Alexey P Ilyn, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 13, 2006
Positive association of schizophrenia to JARID2 geneErika Pedrosa, Kenny Ye, Karen A Nolan, et al.
Journal of Virology|April 5, 2001
L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidationM M Okun, P M Day, H L Greenstone, et al.
Journal of the American Academy of Dermatology|October 11, 2017
Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trialsKenneth B Gordon, Keith A Betts, Murali Sundaram, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 27, 2022
Validation of the Physician's Global Assessment of Fingernail Psoriasis by Rheumatologists Treating Psoriatic ArthritisStacie Hudgens, Cristian Gugiu, Aiste Guobyte, et al.
Journal of Medicinal Chemistry|October 28, 2011
Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonistsAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Biofizika|September 1, 1992
[Osmotic regulation of the sodium pump in rat brain synaptosomes]A A Mongin, S L Aksentsev, A A Rakovich, et al.
The British Journal of Dermatology|November 19, 2010
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapyK Papp, J Crowley, J-P Ortonne, et al.
Transactions of the American Clinical and Climatological Association|January 11, 2013
The impact of race on organ donation authorization discussed in the context of liver transplantationHenry C Bodenheimer, Jeffrey M Okun, Waheed Tajik, et al.
The British Journal of Dermatology|May 9, 2012
Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label studyC Leonardi, J M Sobell, J J Crowley, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitorsDmitri V Kravchenko, Vladimir V Kysil, Alexey P Ilyn, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 13, 2006
Positive association of schizophrenia to JARID2 geneErika Pedrosa, Kenny Ye, Karen A Nolan, et al.
Journal of Virology|April 5, 2001
L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidationM M Okun, P M Day, H L Greenstone, et al.
Journal of the American Academy of Dermatology|October 11, 2017
Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trialsKenneth B Gordon, Keith A Betts, Murali Sundaram, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 27, 2022
Validation of the Physician's Global Assessment of Fingernail Psoriasis by Rheumatologists Treating Psoriatic ArthritisStacie Hudgens, Cristian Gugiu, Aiste Guobyte, et al.
Journal of Medicinal Chemistry|October 28, 2011
Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonistsAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Pageof 11